Антихипотензивни лекови (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Антихипотензивни лекови" in Serbian language version.

refsWebsite

Global rank Serbian rank

19nih.gov

4^th place

8^th place

19doi.org

2^nd place

4^th place

11semanticscholar.org

11^th place

23^rd place

7archive.org

6^th place

5^th place

1cvphysiology.com

low place

5,074^th place

1thefreedictionary.com

614^th place

270^th place

archive.org

Martin, C.; Papazian, L.; Perrin, G.; Saux, P.; Gouin, F. (1993). „Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?”. Chest. 103 (6): 1826—1831. PMID 8404107. doi:10.1378/chest.103.6.1826. .
Hollenberg, S. M.; Ahrens, T. S.; Annane, D.; Astiz, M. E.; Chalfin, D. B.; Dasta, J. F.; Heard, S. O.; Martin, C.; Napolitano, L. M.; Susla, G. M.; Totaro, R.; Vincent, J. L.; Zanotti-Cavazzoni, S. (2004). „Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update”. Crit Care Med. 32 (9): 1928—1948. PMID 15343024. S2CID 2716738. doi:10.1097/01.CCM.0000139761.05492.D6. .
Tulzo, Y. Le; Seguin, P.; Gacouin, A.; Camus, C.; Suprin, E.; Jouannic, I.; Thomas, R. (1997). „Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: A preliminary descriptive study”. Intensive Care Med. 23 (6): 664—670. PMID 9255647. S2CID 22907928. doi:10.1007/s001340050391.
Bollaert, P. E.; Bauer, P.; Audibert, G.; Lambert, H.; Larcan, A. (1990). „Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock”. Chest. 98 (4): 949—953. PMID 2209154. doi:10.1378/chest.98.4.949. .
De Backer D, Creteur J, Silva E, et al: . „Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best?”. Crit Care Med. 31: 1659—1667. 2003. .
Sharshar, T.; Blanchard, A.; Paillard, M.; Raphael, J. C.; Gajdos, P.; Annane, D. (2003). „Circulating vasopressin levels in septic shock”. Crit Care Med. 31 (6): 1752—1758. PMID 12794416. doi:10.1097/01.CCM.0000063046.82359.4A. .
Dünser, M. W.; Mayr, A. J.; Tür, A.; Pajk, W.; Barbara, F.; Knotzer, H.; Ulmer, H.; Hasibeder, W. R. (2003). „Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: Incidence and risk factors”. Crit Care Med. 31 (5): 1394—1398. PMID 12771608. S2CID 11514445. doi:10.1097/01.CCM.0000059722.94182.79.

cvphysiology.com

„CV Physiology | Mean Arterial Pressure”. www.cvphysiology.com. Приступљено 2020-10-12.

doi.org

Martin, C.; Papazian, L.; Perrin, G.; Saux, P.; Gouin, F. (1993). „Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?”. Chest. 103 (6): 1826—1831. PMID 8404107. doi:10.1378/chest.103.6.1826. .
Martin, C.; Viviand, X.; Leone, M.; Thirion, X. (2000). „Effect of norepinephrine on the outcome of septic shock”. Crit Care Med. 28 (8): 2758—2765. PMID 10966247. S2CID 28324851. doi:10.1097/00003246-200008000-00012. .
O'Brien A, Clapp L, Singer M (2002). „Terlipressin for norepinephrine-resistant septic shock”. Lancet. 359 (9313): 1209—10. PMID 11955542. S2CID 38463837. doi:10.1016/S0140-6736(02)08225-9.
Uriz J, Ginès P, Cárdenas A, Sort P, Jiménez W, Salmerón J, Bataller R, Mas A, Navasa M, Arroyo V, Rodés J (2000). „Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome”. J Hepatol. 33 (1): 43—8. PMID 10905585. doi:10.1016/S0168-8278(00)80158-0.
Ioannou G, Doust J, Rockey D (2003). „Terlipressin for acute esophageal variceal hemorrhage”. Cochrane Database Syst Rev (1): CD002147. PMID 12535432. doi:10.1002/14651858.CD002147.
Ledoux, D.; Astiz, M. E.; Carpati, C. M.; Rackow, E. C. (2000). „Effects of perfusion pressure on tissue perfusion in septic shock”. Crit Care Med. 28 (8): 2729—2732. PMID 10966242. S2CID 17345930. doi:10.1097/00003246-200008000-00007.
Hollenberg, S. M.; Ahrens, T. S.; Annane, D.; Astiz, M. E.; Chalfin, D. B.; Dasta, J. F.; Heard, S. O.; Martin, C.; Napolitano, L. M.; Susla, G. M.; Totaro, R.; Vincent, J. L.; Zanotti-Cavazzoni, S. (2004). „Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update”. Crit Care Med. 32 (9): 1928—1948. PMID 15343024. S2CID 2716738. doi:10.1097/01.CCM.0000139761.05492.D6. .
Tulzo, Y. Le; Seguin, P.; Gacouin, A.; Camus, C.; Suprin, E.; Jouannic, I.; Thomas, R. (1997). „Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: A preliminary descriptive study”. Intensive Care Med. 23 (6): 664—670. PMID 9255647. S2CID 22907928. doi:10.1007/s001340050391.
Bollaert, P. E.; Bauer, P.; Audibert, G.; Lambert, H.; Larcan, A. (1990). „Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock”. Chest. 98 (4): 949—953. PMID 2209154. doi:10.1378/chest.98.4.949. .
Landry, Donald W.; Levin, Howard R.; Gallant, Ellen M.; Ashton, Robert C.; Seo, Susan; d'Alessandro, David; Oz, Mehmet C.; Oliver, Juan A. (1997). „Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock”. Circulation. 95 (5): 1122—1125. PMID 9054839. doi:10.1161/01.CIR.95.5.1122. .
Dünser, M. W.; Mayr, A. J.; Ulmer, H.; Knotzer, H.; Sumann, G.; Pajk, W.; Friesenecker, B.; Hasibeder, W. R. (2003). „Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study”. Circulation. 107 (18): 2313—2319. PMID 12732600. S2CID 18037818. doi:10.1161/01.CIR.0000066692.71008.BB. .
Sharshar, T.; Blanchard, A.; Paillard, M.; Raphael, J. C.; Gajdos, P.; Annane, D. (2003). „Circulating vasopressin levels in septic shock”. Crit Care Med. 31 (6): 1752—1758. PMID 12794416. doi:10.1097/01.CCM.0000063046.82359.4A. .
Russell, J. A.; Walley, K. R.; Singer, J.; Gordon, A. C.; Hébert, P. C.; Cooper, D. J.; Holmes, C. L.; Mehta, S.; Granton, J. T.; Storms, M. M.; Cook, D. J.; Presneill, J. J.; Ayers, D.; VASST Investigators (2008). „Vasopressin versus norepinephrine infusion in patients with septic shock”. New England Journal of Medicine. 358 (9): 877—887. PMID 18305265. doi:10.1056/NEJMoa067373. .
Dünser, M. W.; Mayr, A. J.; Tür, A.; Pajk, W.; Barbara, F.; Knotzer, H.; Ulmer, H.; Hasibeder, W. R. (2003). „Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: Incidence and risk factors”. Crit Care Med. 31 (5): 1394—1398. PMID 12771608. S2CID 11514445. doi:10.1097/01.CCM.0000059722.94182.79.
Marik, P. E.; Mohedin, M. (1994). „The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis”. JAMA. 272 (17): 1354—1357. PMID 7933396. doi:10.1001/jama.1994.03520170064037. .
Patel, Gourang P.; Grahe, Jaime Simon; Sperry, Mathew; Singla, Sunit; Elpern, Ellen; Lateef, Omar; Balk, Robert A. (2010). „Efficacy and Safety of Dopamine Versus Norepinephrine in the Management of Septic Shock”. Shock. 33 (4): 375—380. PMID 19851126. S2CID 21089921. doi:10.1097/SHK.0b013e3181c6ba6f. .
De Backer, Daniel; Biston, Patrick; Devriendt, Jacques; Madl, Christian; Chochrad, Didier; Aldecoa, Cesar; Brasseur, Alexandre; Defrance, Pierre; Gottignies, Philippe; Vincent, Jean-Louis (2010). „Comparison of Dopamine and Norepinephrine in the Treatment of Shock”. New England Journal of Medicine. 362 (9): 779—789. PMID 20200382. S2CID 2208904. doi:10.1056/NEJMoa0907118. .
Day, N. P.; Phu, N. H.; Bethell, D. P.; Mai, N. T.; Chau, T. T.; Hien, T. T.; White, N. J. (1996). „The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection”. Lancet. 348 (9022): 219—223. PMID 8684198. S2CID 21140998. doi:10.1016/S0140-6736(96)09096-4. .
Dasta JF, Kirby MG. (1986). „Pharmacology and therapeutic use of low-dose dopamine.”. Pharmacotherapy. 6 (6): 304—10. PMID 3547350. S2CID 24958850. doi:10.1002/j.1875-9114.1986.tb03492.x. .

nih.gov

ncbi.nlm.nih.gov

Martin, C.; Papazian, L.; Perrin, G.; Saux, P.; Gouin, F. (1993). „Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?”. Chest. 103 (6): 1826—1831. PMID 8404107. doi:10.1378/chest.103.6.1826. .
Martin, C.; Viviand, X.; Leone, M.; Thirion, X. (2000). „Effect of norepinephrine on the outcome of septic shock”. Crit Care Med. 28 (8): 2758—2765. PMID 10966247. S2CID 28324851. doi:10.1097/00003246-200008000-00012. .
O'Brien A, Clapp L, Singer M (2002). „Terlipressin for norepinephrine-resistant septic shock”. Lancet. 359 (9313): 1209—10. PMID 11955542. S2CID 38463837. doi:10.1016/S0140-6736(02)08225-9.
Uriz J, Ginès P, Cárdenas A, Sort P, Jiménez W, Salmerón J, Bataller R, Mas A, Navasa M, Arroyo V, Rodés J (2000). „Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome”. J Hepatol. 33 (1): 43—8. PMID 10905585. doi:10.1016/S0168-8278(00)80158-0.
Ioannou G, Doust J, Rockey D (2003). „Terlipressin for acute esophageal variceal hemorrhage”. Cochrane Database Syst Rev (1): CD002147. PMID 12535432. doi:10.1002/14651858.CD002147.
Ledoux, D.; Astiz, M. E.; Carpati, C. M.; Rackow, E. C. (2000). „Effects of perfusion pressure on tissue perfusion in septic shock”. Crit Care Med. 28 (8): 2729—2732. PMID 10966242. S2CID 17345930. doi:10.1097/00003246-200008000-00007.
Hollenberg, S. M.; Ahrens, T. S.; Annane, D.; Astiz, M. E.; Chalfin, D. B.; Dasta, J. F.; Heard, S. O.; Martin, C.; Napolitano, L. M.; Susla, G. M.; Totaro, R.; Vincent, J. L.; Zanotti-Cavazzoni, S. (2004). „Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update”. Crit Care Med. 32 (9): 1928—1948. PMID 15343024. S2CID 2716738. doi:10.1097/01.CCM.0000139761.05492.D6. .
Tulzo, Y. Le; Seguin, P.; Gacouin, A.; Camus, C.; Suprin, E.; Jouannic, I.; Thomas, R. (1997). „Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: A preliminary descriptive study”. Intensive Care Med. 23 (6): 664—670. PMID 9255647. S2CID 22907928. doi:10.1007/s001340050391.
Bollaert, P. E.; Bauer, P.; Audibert, G.; Lambert, H.; Larcan, A. (1990). „Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock”. Chest. 98 (4): 949—953. PMID 2209154. doi:10.1378/chest.98.4.949. .
Landry, Donald W.; Levin, Howard R.; Gallant, Ellen M.; Ashton, Robert C.; Seo, Susan; d'Alessandro, David; Oz, Mehmet C.; Oliver, Juan A. (1997). „Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock”. Circulation. 95 (5): 1122—1125. PMID 9054839. doi:10.1161/01.CIR.95.5.1122. .
Dünser, M. W.; Mayr, A. J.; Ulmer, H.; Knotzer, H.; Sumann, G.; Pajk, W.; Friesenecker, B.; Hasibeder, W. R. (2003). „Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study”. Circulation. 107 (18): 2313—2319. PMID 12732600. S2CID 18037818. doi:10.1161/01.CIR.0000066692.71008.BB. .
Sharshar, T.; Blanchard, A.; Paillard, M.; Raphael, J. C.; Gajdos, P.; Annane, D. (2003). „Circulating vasopressin levels in septic shock”. Crit Care Med. 31 (6): 1752—1758. PMID 12794416. doi:10.1097/01.CCM.0000063046.82359.4A. .
Russell, J. A.; Walley, K. R.; Singer, J.; Gordon, A. C.; Hébert, P. C.; Cooper, D. J.; Holmes, C. L.; Mehta, S.; Granton, J. T.; Storms, M. M.; Cook, D. J.; Presneill, J. J.; Ayers, D.; VASST Investigators (2008). „Vasopressin versus norepinephrine infusion in patients with septic shock”. New England Journal of Medicine. 358 (9): 877—887. PMID 18305265. doi:10.1056/NEJMoa067373. .
Dünser, M. W.; Mayr, A. J.; Tür, A.; Pajk, W.; Barbara, F.; Knotzer, H.; Ulmer, H.; Hasibeder, W. R. (2003). „Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: Incidence and risk factors”. Crit Care Med. 31 (5): 1394—1398. PMID 12771608. S2CID 11514445. doi:10.1097/01.CCM.0000059722.94182.79.
Marik, P. E.; Mohedin, M. (1994). „The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis”. JAMA. 272 (17): 1354—1357. PMID 7933396. doi:10.1001/jama.1994.03520170064037. .
Patel, Gourang P.; Grahe, Jaime Simon; Sperry, Mathew; Singla, Sunit; Elpern, Ellen; Lateef, Omar; Balk, Robert A. (2010). „Efficacy and Safety of Dopamine Versus Norepinephrine in the Management of Septic Shock”. Shock. 33 (4): 375—380. PMID 19851126. S2CID 21089921. doi:10.1097/SHK.0b013e3181c6ba6f. .
De Backer, Daniel; Biston, Patrick; Devriendt, Jacques; Madl, Christian; Chochrad, Didier; Aldecoa, Cesar; Brasseur, Alexandre; Defrance, Pierre; Gottignies, Philippe; Vincent, Jean-Louis (2010). „Comparison of Dopamine and Norepinephrine in the Treatment of Shock”. New England Journal of Medicine. 362 (9): 779—789. PMID 20200382. S2CID 2208904. doi:10.1056/NEJMoa0907118. .
Day, N. P.; Phu, N. H.; Bethell, D. P.; Mai, N. T.; Chau, T. T.; Hien, T. T.; White, N. J. (1996). „The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection”. Lancet. 348 (9022): 219—223. PMID 8684198. S2CID 21140998. doi:10.1016/S0140-6736(96)09096-4. .
Dasta JF, Kirby MG. (1986). „Pharmacology and therapeutic use of low-dose dopamine.”. Pharmacotherapy. 6 (6): 304—10. PMID 3547350. S2CID 24958850. doi:10.1002/j.1875-9114.1986.tb03492.x. .

semanticscholar.org

api.semanticscholar.org

Martin, C.; Viviand, X.; Leone, M.; Thirion, X. (2000). „Effect of norepinephrine on the outcome of septic shock”. Crit Care Med. 28 (8): 2758—2765. PMID 10966247. S2CID 28324851. doi:10.1097/00003246-200008000-00012. .
O'Brien A, Clapp L, Singer M (2002). „Terlipressin for norepinephrine-resistant septic shock”. Lancet. 359 (9313): 1209—10. PMID 11955542. S2CID 38463837. doi:10.1016/S0140-6736(02)08225-9.
Ledoux, D.; Astiz, M. E.; Carpati, C. M.; Rackow, E. C. (2000). „Effects of perfusion pressure on tissue perfusion in septic shock”. Crit Care Med. 28 (8): 2729—2732. PMID 10966242. S2CID 17345930. doi:10.1097/00003246-200008000-00007.
Hollenberg, S. M.; Ahrens, T. S.; Annane, D.; Astiz, M. E.; Chalfin, D. B.; Dasta, J. F.; Heard, S. O.; Martin, C.; Napolitano, L. M.; Susla, G. M.; Totaro, R.; Vincent, J. L.; Zanotti-Cavazzoni, S. (2004). „Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update”. Crit Care Med. 32 (9): 1928—1948. PMID 15343024. S2CID 2716738. doi:10.1097/01.CCM.0000139761.05492.D6. .
Tulzo, Y. Le; Seguin, P.; Gacouin, A.; Camus, C.; Suprin, E.; Jouannic, I.; Thomas, R. (1997). „Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: A preliminary descriptive study”. Intensive Care Med. 23 (6): 664—670. PMID 9255647. S2CID 22907928. doi:10.1007/s001340050391.
Dünser, M. W.; Mayr, A. J.; Ulmer, H.; Knotzer, H.; Sumann, G.; Pajk, W.; Friesenecker, B.; Hasibeder, W. R. (2003). „Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study”. Circulation. 107 (18): 2313—2319. PMID 12732600. S2CID 18037818. doi:10.1161/01.CIR.0000066692.71008.BB. .
Dünser, M. W.; Mayr, A. J.; Tür, A.; Pajk, W.; Barbara, F.; Knotzer, H.; Ulmer, H.; Hasibeder, W. R. (2003). „Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: Incidence and risk factors”. Crit Care Med. 31 (5): 1394—1398. PMID 12771608. S2CID 11514445. doi:10.1097/01.CCM.0000059722.94182.79.
Patel, Gourang P.; Grahe, Jaime Simon; Sperry, Mathew; Singla, Sunit; Elpern, Ellen; Lateef, Omar; Balk, Robert A. (2010). „Efficacy and Safety of Dopamine Versus Norepinephrine in the Management of Septic Shock”. Shock. 33 (4): 375—380. PMID 19851126. S2CID 21089921. doi:10.1097/SHK.0b013e3181c6ba6f. .
De Backer, Daniel; Biston, Patrick; Devriendt, Jacques; Madl, Christian; Chochrad, Didier; Aldecoa, Cesar; Brasseur, Alexandre; Defrance, Pierre; Gottignies, Philippe; Vincent, Jean-Louis (2010). „Comparison of Dopamine and Norepinephrine in the Treatment of Shock”. New England Journal of Medicine. 362 (9): 779—789. PMID 20200382. S2CID 2208904. doi:10.1056/NEJMoa0907118. .
Day, N. P.; Phu, N. H.; Bethell, D. P.; Mai, N. T.; Chau, T. T.; Hien, T. T.; White, N. J. (1996). „The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection”. Lancet. 348 (9022): 219—223. PMID 8684198. S2CID 21140998. doi:10.1016/S0140-6736(96)09096-4. .
Dasta JF, Kirby MG. (1986). „Pharmacology and therapeutic use of low-dose dopamine.”. Pharmacotherapy. 6 (6): 304—10. PMID 3547350. S2CID 24958850. doi:10.1002/j.1875-9114.1986.tb03492.x. .

thefreedictionary.com

medical-dictionary.thefreedictionary.com

The Free medical-dictionary, vasopressor Приступљено, 15.1.2014.